Compare MIRA & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIRA | CRT |
|---|---|---|
| Founded | 2020 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.3M | 42.5M |
| IPO Year | 2023 | 1992 |
| Metric | MIRA | CRT |
|---|---|---|
| Price | $1.18 | $8.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 170.3K | 26.8K |
| Earning Date | 03-27-2026 | 03-12-2026 |
| Dividend Yield | N/A | ★ 8.06% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | ★ $5,621,913.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.48 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.73 | $7.07 |
| 52 Week High | $2.45 | $13.31 |
| Indicator | MIRA | CRT |
|---|---|---|
| Relative Strength Index (RSI) | 34.16 | 51.81 |
| Support Level | $1.13 | $8.35 |
| Resistance Level | $1.25 | $8.65 |
| Average True Range (ATR) | 0.07 | 0.25 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 16.18 | 34.93 |
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.